ZA200201409B - Novel A-500359 derivatives. - Google Patents

Novel A-500359 derivatives. Download PDF

Info

Publication number
ZA200201409B
ZA200201409B ZA200201409A ZA200201409A ZA200201409B ZA 200201409 B ZA200201409 B ZA 200201409B ZA 200201409 A ZA200201409 A ZA 200201409A ZA 200201409 A ZA200201409 A ZA 200201409A ZA 200201409 B ZA200201409 B ZA 200201409B
Authority
ZA
South Africa
Prior art keywords
group
pharmaceutically acceptable
compound
substituents
alkyl
Prior art date
Application number
ZA200201409A
Other languages
English (en)
Inventor
Hitoshi Hotoda
Masatoshi Inukai
Yukio Utsui
Masakatsu Kaneko
Yasunori Muramatsu
Satoshi Ohya
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of ZA200201409B publication Critical patent/ZA200201409B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/08Antibacterial agents for leprosy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/067Pyrimidine radicals with ribosyl as the saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200201409A 1999-08-20 2002-02-19 Novel A-500359 derivatives. ZA200201409B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23393499 1999-08-20

Publications (1)

Publication Number Publication Date
ZA200201409B true ZA200201409B (en) 2003-07-30

Family

ID=16962911

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200201409A ZA200201409B (en) 1999-08-20 2002-02-19 Novel A-500359 derivatives.

Country Status (24)

Country Link
US (1) US7157442B2 (de)
EP (1) EP1209166B1 (de)
KR (1) KR100787849B1 (de)
CN (1) CN1176936C (de)
AT (1) ATE263183T1 (de)
AU (1) AU763492B2 (de)
BR (1) BR0013435A (de)
CA (1) CA2382654C (de)
CZ (1) CZ2002682A3 (de)
DE (1) DE60009517T2 (de)
DK (1) DK1209166T3 (de)
ES (1) ES2216933T3 (de)
HU (1) HUP0204217A3 (de)
IL (2) IL148196A0 (de)
MX (1) MXPA02001817A (de)
NO (1) NO323556B1 (de)
NZ (1) NZ517315A (de)
PL (1) PL353494A1 (de)
PT (1) PT1209166E (de)
RU (1) RU2227799C2 (de)
TR (1) TR200200485T2 (de)
TW (1) TWI245047B (de)
WO (1) WO2001014399A1 (de)
ZA (1) ZA200201409B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9911965A (pt) * 1998-07-09 2001-05-29 Sankyo Co Composto, derivado de éster, éter ou n-alquilcarbamoìla farmaceuticamente aceitáveis, composição farmacêutica, uso de um composto, processo para o tratamento ou prevenção de uma infecção bacteriana, streptomices griseus, derivado de amida, processo para preparar um composto, e, cepa de streptomyces griseus
CN101404986B (zh) * 2002-05-17 2011-09-28 赛奎拉公司 用于诊断和治疗感染性疾病的组合物和制药方法
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
US7456222B2 (en) * 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
EP1670314A4 (de) * 2003-09-05 2009-02-25 Sequella Inc Verfahren und zusammensetzungen enthaltend diamine als neue therapeutika für tuberkulose
US20090281054A1 (en) * 2008-05-06 2009-11-12 Venkata Reddy Compositions and methods comprising capuramycin analogues
KR101104505B1 (ko) * 2010-01-30 2012-01-12 김근섭 호스 연결용 원클릭 피팅
WO2015027137A1 (en) * 2013-08-23 2015-02-26 University Of Tennessee Research Foundation Improved synthesis of capuramycin and its analogues
WO2022006231A1 (en) * 2020-06-30 2022-01-06 University Of Tennessee Research Foundation Dpagt1 inhibitors of capuramycin analogues and their antimigratory activities of solid tumors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60259190A (ja) * 1984-06-06 1985-12-21 Kanto Ishi Pharma Co Ltd 新抗生物質カプラマイシン及びその製造法
US5034381A (en) * 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives
JPH05148293A (ja) * 1991-11-28 1993-06-15 Mect Corp 新規カプラマイシン誘導体およびその製造方法
GB9307043D0 (en) 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
BR9911965A (pt) 1998-07-09 2001-05-29 Sankyo Co Composto, derivado de éster, éter ou n-alquilcarbamoìla farmaceuticamente aceitáveis, composição farmacêutica, uso de um composto, processo para o tratamento ou prevenção de uma infecção bacteriana, streptomices griseus, derivado de amida, processo para preparar um composto, e, cepa de streptomyces griseus
JP4428762B2 (ja) 1998-07-09 2010-03-10 セケラ インコーポレイテッド 抗生物質a−500359及び誘導体
JP2000072774A (ja) * 1998-08-25 2000-03-07 Sankyo Co Ltd ラクトン誘導体
JP4531167B2 (ja) 1998-09-24 2010-08-25 セケラ インコーポレイテッド 新規抗細菌化合物
JP4960548B2 (ja) * 2000-01-07 2012-06-27 セケラ インコーポレイテッド 新規抗細菌化合物の用途
JP5022539B2 (ja) 2000-01-07 2012-09-12 セケラ インコーポレイテッド 抗生物質a−500359及び誘導体を含有する抗菌剤

Also Published As

Publication number Publication date
US7157442B2 (en) 2007-01-02
WO2001014399A1 (fr) 2001-03-01
ES2216933T3 (es) 2004-11-01
CZ2002682A3 (cs) 2002-06-12
MXPA02001817A (es) 2002-08-12
EP1209166A4 (de) 2002-10-09
CA2382654A1 (en) 2001-03-01
NO20020804D0 (no) 2002-02-19
TR200200485T2 (tr) 2002-06-21
PT1209166E (pt) 2004-06-30
KR20020092901A (ko) 2002-12-12
EP1209166A1 (de) 2002-05-29
BR0013435A (pt) 2002-07-16
DK1209166T3 (da) 2004-07-26
DE60009517D1 (de) 2004-05-06
DE60009517T2 (de) 2005-01-13
RU2227799C2 (ru) 2004-04-27
IL148196A0 (en) 2002-09-12
IL148196A (en) 2008-06-05
ATE263183T1 (de) 2004-04-15
KR100787849B1 (ko) 2007-12-27
CN1176936C (zh) 2004-11-24
NO20020804L (no) 2002-04-19
HK1044951A1 (en) 2002-11-08
CN1382152A (zh) 2002-11-27
AU763492B2 (en) 2003-07-24
EP1209166B1 (de) 2004-03-31
US20030171330A1 (en) 2003-09-11
HUP0204217A2 (en) 2003-03-28
PL353494A1 (en) 2003-11-17
AU6595500A (en) 2001-03-19
NO323556B1 (no) 2007-06-11
HUP0204217A3 (en) 2005-11-28
TWI245047B (en) 2005-12-11
NZ517315A (en) 2004-02-27
CA2382654C (en) 2009-01-13

Similar Documents

Publication Publication Date Title
ZA200201409B (en) Novel A-500359 derivatives.
JP3808095B2 (ja) 四環式誘導体、製造方法および用途
FI88163C (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara pyrazolo/3,4-d/pyrimidiner
ZA200207956B (en) 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors.
EP1660475B1 (de) Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken
KR20090101278A (ko) 누클레오시다제 및 포스포릴라제 억제제의 아제티딘 유사체
PE20081377A1 (es) Compuestos de tiazol pirazolopirimidina
NO20082338L (no) Pyrimidinderivater for behandling av avvikende cellevekst
RU2005116239A (ru) Замещенный 4-амино-1-(пиридилметил)пиперидин в качестве антагонистов мускариновых рецепторов
CA2412164A1 (en) Amidine derivatives as selective antagonists of nmda receptors
CN102816165A (zh) 氨基-氮杂-金刚烷衍生物和使用方法
US20050043323A1 (en) Pyrimidylpyrrole derivatives active as kinase inhibitors
ZA200100200B (en) Novel antibacterial compounds
JP4162840B2 (ja) 新規a−500359誘導体
JP4658438B2 (ja) 新規a−500359誘導体を含有する抗菌剤
AU2019235042B2 (en) Substituted pyridopyrrolopyrimidine ribonucleosides for therapeutic uses
CA2287465A1 (en) 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
NZ584037A (en) Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same
NZ337125A (en) 5,6,7-trisubstituted-4-amino-pyrido[2,3-d]pyrimidine compounds useful for inhibiting adenosine kinase
HK1044951B (en) Novel a-500359 derivatives
RU2415852C2 (ru) Производные пиразолиламинопиридина, пригодные в качестве ингибиторов киназы
TH82131A (th) ไธอีโน [2,3-ดี] พัยริมิดีนที่มีฤทธิ์แอโกนิสท์ของ lh และ fsh รวมกัน
BR0014668A (pt) Derivados de piperidina como inibidores de reabsorção de serotonina
CZ350899A3 (cs) 5,6,7-trisubstituované-4-aminopyrido-[2,3- D]pyrimidinové sloučeniny